NUAK1 knockdown suppresses prostate cancer cell epithelial-mesenchymal transition, migration, and invasion through

Yongjun Guan1, Hongbo Shi1, Tianlin Xiao1

  • 1Department of Urology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science China.

Abstract

Insights

Novel kinase family 1 (NUAK1) and microRNA-30b-5p (miRNA-30b-5p) are crucial for prostate cancer progression. Inhibiting NUAK1 can limit cancer cell invasion and migration, offering a potential therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Prostate cancer is a leading malignancy in men globally.
  • The role of Novel (NU) kinase family 1 (NUAK1) in prostate cancer development is not fully understood.
  • NUAK1 is an AMP-activated protein kinase family member implicated in various cancers.

Purpose of the Study:

  • To investigate the biological role of NUAK1 in prostate cancer.
  • To elucidate the relationship between NUAK1 and microRNA-30b-5p (miRNA-30b-5p) in prostate cancer.
  • To assess the potential of targeting NUAK1 for prostate cancer therapy.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) to measure NUAK1 and miRNA-30b-5p expression.
  • Western blot analysis for epithelial-mesenchymal transition (EMT) markers and NUAK1 protein.
  • Trans-well assays for cell migration and invasion.
  • Luciferase reporter assays to confirm NUAK1-miRNA-30b-5p interaction.

Main Results:

  • NUAK1 expression was significantly elevated in prostate cancer tissues and cell lines.
  • NUAK1 knockdown suppressed prostate cancer cell EMT, migration, and invasion.
  • NUAK1 was identified as a direct target of miRNA-30b-5p.
  • miRNA-30b-5p inhibited prostate cancer cell EMT, migration, and invasion, an effect reversed by NUAK1 overexpression.

Conclusions:

  • Both NUAK1 and miRNA-30b-5p play essential roles in prostate cancer progression.
  • NUAK1 interference, mediated by miRNA-30b-5p, effectively limits prostate cancer cell EMT, migration, and invasion.
  • Targeting the NUAK1/miRNA-30b-5p axis presents a promising therapeutic avenue for prostate cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K